首页 > 最新文献

Current Research in Pharmacology and Drug Discovery最新文献

英文 中文
Characterization of 2-((4-(chloromethyl)benzoyl)oxy)benzoate acid for analgesic tablet dosage form formulation 用于镇痛片剂配方的 2-((4-(氯甲基)苯甲酰基)氧基)苯甲酸的表征
Q2 Agricultural and Biological Sciences Pub Date : 2024-01-01 DOI: 10.1016/j.crphar.2024.100200
Wuryanto Hadinugroho, Yudy Tjahjono, Kuncoro Foe, Senny Yesery Esar, Caroline Caroline, Maria Annabella Jessica, Hendy Wijaya

The 2-((4-(chloromethyl)benzoyl)oxy)benzoic acid (4CH2Cl) is a potential analgesic compound derived from salicylic acid and 4-chloromethyl benzoyl chloride. Characterization required 4CH2Cl for the formulation of tablet dosage forms. This study aims investigate the effect of SSG, PVP-K30, and the combination of SSG*PVP K-30 on the formulation of 4CH2Cl tablets. Additionally, this study aimed to obtain the optimum 4CH2Cl tablet composition. The experiment followed the two-factor simplex lattice design and direct compression method. The analgesic activity of 4CH2Cl in the optimal tablet was investigated using the hot-plate methods. The ANOVA of linear models is acceptable and the polynomial coefficients of quadratic models are similar to those of linear models. The coefficient of the linear model shows that SSG and PVP K-30 increase the Carr index (16.26; 20.61), Hausner ratio (1.19; 1.29), hardness (4.19; 9.39), friability (0.48; 0.67), disintegration time (0.34; 7.50), and drug release (85.29; 97.69). The coefficient of the quadratic model shows that SSG*PVP K-30 increased the Carr index (1.90), Hausner ratio (0.04), hardness (1.88), friability (0.06), and drug release (4.56), and decreased disintegration time (−0.30). SSG and PVP K-30 increased Carr index, Hausner ratio, hardness, friability, disintegration time, and drug release. The combination of SSG*PVP K-30 has the same effect, except that the disintegration time decreased. The optimum tablet formula is 4CH2Cl (300 mg), Ne (75 mg), SSG (33.60 mg), PVP K-30 (22.40 mg), MCC (40 mg), and SDL (up to 800 mg). 4CH2Cl tablets can be a candidate and choice for new analgesic drugs in the future.

2-((4-(氯甲基)苯甲酰基)氧基)苯甲酸(4CH2Cl)是一种潜在的镇痛化合物,由水杨酸和 4-氯甲基苯甲酰氯衍生而来。制备片剂需要 4CH2Cl 的特性。本研究旨在探讨 SSG、PVP-K30 以及 SSG*PVP K-30 组合对 4CH2Cl 片剂配方的影响。此外,本研究还旨在获得最佳的 4CH2Cl 片剂成分。实验采用了双因素简格设计和直接压片法。采用热板法研究了最佳片剂中 4CH2Cl 的镇痛活性。线性模型的方差分析是可以接受的,二次模型的多项式系数与线性模型相似。线性模型的系数表明,SSG 和 PVP K-30 增加了卡尔指数(16.26;20.61)、豪斯纳比率(1.19;1.29)、硬度(4.19;9.39)、易碎性(0.48;0.67)、崩解时间(0.34;7.50)和药物释放(85.29;97.69)。二次模型系数显示,SSG*PVP K-30 增加了 Carr 指数(1.90)、豪斯纳比率(0.04)、硬度(1.88)、易碎性(0.06)和药物释放(4.56),减少了崩解时间(-0.30)。SSG 和 PVP K-30 增加了卡尔指数、豪斯纳比率、硬度、易碎性、崩解时间和药物释放。SSG*PVP K-30 的组合效果相同,只是崩解时间缩短。最佳片剂配方为:4CH2Cl(300 毫克)、Ne(75 毫克)、SSG(33.60 毫克)、PVP K-30(22.40 毫克)、MCC(40 毫克)和 SDL(最多 800 毫克)。4CH2Cl 片剂可作为未来新型镇痛药物的候选和选择。
{"title":"Characterization of 2-((4-(chloromethyl)benzoyl)oxy)benzoate acid for analgesic tablet dosage form formulation","authors":"Wuryanto Hadinugroho,&nbsp;Yudy Tjahjono,&nbsp;Kuncoro Foe,&nbsp;Senny Yesery Esar,&nbsp;Caroline Caroline,&nbsp;Maria Annabella Jessica,&nbsp;Hendy Wijaya","doi":"10.1016/j.crphar.2024.100200","DOIUrl":"10.1016/j.crphar.2024.100200","url":null,"abstract":"<div><p>The 2-((4-(chloromethyl)benzoyl)oxy)benzoic acid (4CH<sub>2</sub>Cl) is a potential analgesic compound derived from salicylic acid and 4-chloromethyl benzoyl chloride. Characterization required 4CH<sub>2</sub>Cl for the formulation of tablet dosage forms. This study aims investigate the effect of SSG, PVP-K30, and the combination of SSG*PVP K-30 on the formulation of 4CH<sub>2</sub>Cl tablets. Additionally, this study aimed to obtain the optimum 4CH<sub>2</sub>Cl tablet composition. The experiment followed the two-factor simplex lattice design and direct compression method. The analgesic activity of 4CH<sub>2</sub>Cl in the optimal tablet was investigated using the hot-plate methods. The ANOVA of linear models is acceptable and the polynomial coefficients of quadratic models are similar to those of linear models. The coefficient of the linear model shows that SSG and PVP K-30 increase the Carr index (16.26; 20.61), Hausner ratio (1.19; 1.29), hardness (4.19; 9.39), friability (0.48; 0.67), disintegration time (0.34; 7.50), and drug release (85.29; 97.69). The coefficient of the quadratic model shows that SSG*PVP K-30 increased the Carr index (1.90), Hausner ratio (0.04), hardness (1.88), friability (0.06), and drug release (4.56), and decreased disintegration time (−0.30). SSG and PVP K-30 increased Carr index, Hausner ratio, hardness, friability, disintegration time, and drug release. The combination of SSG*PVP K-30 has the same effect, except that the disintegration time decreased. The optimum tablet formula is 4CH<sub>2</sub>Cl (300 mg), Ne (75 mg), SSG (33.60 mg), PVP K-30 (22.40 mg), MCC (40 mg), and SDL (up to 800 mg). 4CH<sub>2</sub>Cl tablets can be a candidate and choice for new analgesic drugs in the future.</p></div>","PeriodicalId":10877,"journal":{"name":"Current Research in Pharmacology and Drug Discovery","volume":"7 ","pages":"Article 100200"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590257124000270/pdfft?md5=a80324e5d165886f3005648cc749103b&pid=1-s2.0-S2590257124000270-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142230012","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Stem cell therapy as a promising approach for ischemic stroke treatment 干细胞疗法是治疗缺血性中风的有效方法
Q2 Agricultural and Biological Sciences Pub Date : 2024-01-01 DOI: 10.1016/j.crphar.2024.100183
Sahar Yaqubi, Mohammad Karimian

Ischemia as the most common type of stroke is the main cause of death and disability in the world. However, there are few therapeutic approaches to treat ischemic stroke. The common approach to the treatment of ischemia includes surgery-cum-chemical drugs. Surgery and chemical drugs are used to remove blood clots to prevent the deterioration of the nervous system. Given the surgical hazards and the challenges associated with chemical drugs, these cannot be considered safe approaches to the treatment of brain ischemia. Besides surgery-cum-chemical drugs, different types of stem cells including mesenchymal stem cells and neurological stem cells have been considered to treat ischemic stroke. Therapeutic approaches utilizing stem cells to treat strokes are promising because of their neuroprotective and regenerative benefits. However, the mechanisms by which the transplanted stem cells perform their precisely actions are unknown. The purpose of this study is to critically review stem cell-based therapeutic approaches for ischemia along with related challenges.

缺血性中风是最常见的中风类型,也是世界上导致死亡和残疾的主要原因。然而,治疗缺血性中风的方法很少。治疗缺血性中风的常用方法包括手术和化学药物。手术和化学药物用于清除血凝块,防止神经系统恶化。鉴于手术的危险性和化学药物带来的挑战,这些都不能被视为治疗脑缺血的安全方法。除了手术和化学药物外,不同类型的干细胞(包括间充质干细胞和神经干细胞)也被用来治疗缺血性中风。利用干细胞治疗中风的方法很有前景,因为干细胞具有神经保护和再生功能。然而,移植干细胞发挥精确作用的机制尚不清楚。本研究的目的是对基于干细胞的缺血治疗方法及相关挑战进行批判性回顾。
{"title":"Stem cell therapy as a promising approach for ischemic stroke treatment","authors":"Sahar Yaqubi,&nbsp;Mohammad Karimian","doi":"10.1016/j.crphar.2024.100183","DOIUrl":"10.1016/j.crphar.2024.100183","url":null,"abstract":"<div><p>Ischemia as the most common type of stroke is the main cause of death and disability in the world. However, there are few therapeutic approaches to treat ischemic stroke. The common approach to the treatment of ischemia includes surgery-cum-chemical drugs. Surgery and chemical drugs are used to remove blood clots to prevent the deterioration of the nervous system. Given the surgical hazards and the challenges associated with chemical drugs, these cannot be considered safe approaches to the treatment of brain ischemia. Besides surgery-cum-chemical drugs, different types of stem cells including mesenchymal stem cells and neurological stem cells have been considered to treat ischemic stroke. Therapeutic approaches utilizing stem cells to treat strokes are promising because of their neuroprotective and regenerative benefits. However, the mechanisms by which the transplanted stem cells perform their precisely actions are unknown. The purpose of this study is to critically review stem cell-based therapeutic approaches for ischemia along with related challenges.</p></div>","PeriodicalId":10877,"journal":{"name":"Current Research in Pharmacology and Drug Discovery","volume":"6 ","pages":"Article 100183"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590257124000105/pdfft?md5=4930984c2fd48472ce800fface90619c&pid=1-s2.0-S2590257124000105-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141032993","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Papaverine attenuates the progression of alpha naphthylisothiocyanate induce cholestasis in rats 木蝴蝶碱可减轻α-萘基异硫氰酸盐诱导大鼠胆汁淤积症的进展
Q2 Agricultural and Biological Sciences Pub Date : 2024-01-01 DOI: 10.1016/j.crphar.2024.100177
Doaa Adnan Atshan , Munaf Hashim Zalzala

Cholestasis is a hepatobiliary condition that manifests as acute or chronic and results from disruptions in the bile flow, formation, or secretion processes. The Farnesoid X receptor (FXR) is a vital target for the therapy of cholestasis since it regulates BA homeostasis. Despite the discovery of multiple active FXR agonists, there are still no effective treatments for cholestasis. Papaverine is identified as an FXR agonist.This study investigates papaverine's efficacy and probable mechanism in protecting against alpha naphthylisothiocyanate (ANIT) induced cholestasis. Thirty male albino rats were divided into three groups, each with ten rats. Group I (control) rats were administered 1 mL/kg corn oil 48 h before sacrifice; group II rats were orally administered 100 mg/kg ANIT. Group III received a 200 mg/kg dosage of papaverine over seven consecutive days. A single dose of ANIT at a concentration of 100 mg/kg was orally administered on the fifth day; group II and III animals were euthanized 48 h after inducing cholestasis, and serum concentrations of liver function tests and total bile acid (TBA) were measured. Besides measuring the inflammatory mediator's tumor necrosis factor-alpha (TNF-α) and interleukin 1 (IL-1β), antioxidant markers such as superoxide dismutase (SOD) and glutathione (GSH) were also assessed. The findings indicated the enhancement in the liver function test and total bile acids, as well as in liver histology; papaverine significantly lowered TNF-α and IL-1β while SOD and GSH significantly increased. Additionally, papaverine upregulates Fxr gene expression, bile salt export pump (Besp), small heterodimer partner (shp), hepatocyte nuclear factor 1α (Hnfα), nuclear factor erythroid 2-related factor (Nrf2), heme oxygenase (Ho-1), NAD(P)H quinone oxidoreductase 1 (Nqo1). Furthermore, papaverine increased protein expressions of Sirtuin1.

(SIRT 1), FXR, HO-1, and BSEP levels in the rats' livers. The protective effects of papaverine may be attributed to the activation of FXR signaling pathways. These findings revealed that papaverine protects against ANIT-induced Cholestasis.

胆汁淤积症是一种肝胆疾病,可表现为急性或慢性,是胆汁流动、形成或分泌过程紊乱的结果。法尼类固醇 X 受体(FXR)是治疗胆汁淤积症的重要靶点,因为它能调节胆汁酸的平衡。尽管发现了多种活性 FXR 激动剂,但胆汁淤积症仍然没有有效的治疗方法。本研究探讨了木蝴蝶碱在抗α-萘基异硫氰酸盐(ANIT)诱导的胆汁淤积症方面的功效和可能机制。30 只雄性白化大鼠被分为三组,每组 10 只。第一组(对照组)大鼠在牺牲前 48 小时服用 1 毫升/千克玉米油;第二组大鼠口服 100 毫克/千克 ANIT。第三组连续七天服用 200 毫克/千克的罂粟碱。第五天口服单剂量浓度为 100 毫克/千克的 ANIT;诱导胆汁淤积 48 小时后,对 II 组和 III 组动物实施安乐死,并测量血清中的肝功能检测指标和总胆汁酸(TBA)浓度。除了检测炎症介质肿瘤坏死因子α(TNF-α)和白细胞介素1(IL-1β)外,还评估了超氧化物歧化酶(SOD)和谷胱甘肽(GSH)等抗氧化指标。研究结果表明,肝功能测试和总胆汁酸以及肝组织学均有改善;木瓜碱显著降低了 TNF-α 和 IL-1β,而 SOD 和 GSH 则显著增加。此外,木瓜碱还能上调 Fxr 基因、胆盐输出泵(Besp)、小异二聚体伙伴(shp)、肝细胞核因子 1α (Hnfα)、红细胞核因子 2 相关因子(Nrf2)、血红素加氧酶(Ho-1)、NAD(P)H 醌氧化还原酶 1(Nqo1)的表达。此外,木瓜碱还能增加大鼠肝脏中Sirtuin1(SIRT 1)、FXR、HO-1和BSEP的蛋白表达量。罂粟碱的保护作用可能是由于激活了FXR信号通路。这些研究结果表明,木蝴蝶碱对ANIT诱导的胆汁淤积症具有保护作用。
{"title":"Papaverine attenuates the progression of alpha naphthylisothiocyanate induce cholestasis in rats","authors":"Doaa Adnan Atshan ,&nbsp;Munaf Hashim Zalzala","doi":"10.1016/j.crphar.2024.100177","DOIUrl":"https://doi.org/10.1016/j.crphar.2024.100177","url":null,"abstract":"<div><p>Cholestasis is a hepatobiliary condition that manifests as acute or chronic and results from disruptions in the bile flow, formation, or secretion processes. The Farnesoid X receptor (FXR) is a vital target for the therapy of cholestasis since it regulates BA homeostasis. Despite the discovery of multiple active FXR agonists, there are still no effective treatments for cholestasis. Papaverine is identified as an FXR agonist.This study investigates papaverine's efficacy and probable mechanism in protecting against alpha naphthylisothiocyanate (ANIT) induced cholestasis. Thirty male albino rats were divided into three groups, each with ten rats. Group I (control) rats were administered 1 mL/kg corn oil 48 h before sacrifice; group II rats were orally administered 100 mg/kg ANIT. Group III received a 200 mg/kg dosage of papaverine over seven consecutive days. A single dose of ANIT at a concentration of 100 mg/kg was orally administered on the fifth day; group II and III animals were euthanized 48 h after inducing cholestasis, and serum concentrations of liver function tests and total bile acid (TBA) were measured. Besides measuring the inflammatory mediator's tumor necrosis factor-alpha (TNF-α) and interleukin 1 (IL-1β), antioxidant markers such as superoxide dismutase (SOD) and glutathione (GSH) were also assessed. The findings indicated the enhancement in the liver function test and total bile acids, as well as in liver histology; papaverine significantly lowered TNF-α and IL-1β while SOD and GSH significantly increased. Additionally, papaverine upregulates <em>Fxr</em> gene expression, bile salt export pump (<em>Besp</em>), small heterodimer partner (<em>shp</em>), hepatocyte nuclear factor 1α (<em>Hnfα</em>), nuclear factor erythroid 2-related factor (<em>Nrf2</em>), heme oxygenase (<em>Ho-1</em>), NAD(P)H quinone oxidoreductase 1 (<em>Nqo1</em>). Furthermore, papaverine increased protein expressions of Sirtuin1.</p><p>(SIRT 1), FXR, HO-1, and BSEP levels in the rats' livers. The protective effects of papaverine may be attributed to the activation of FXR signaling pathways. These findings revealed that papaverine protects against ANIT-induced Cholestasis.</p></div>","PeriodicalId":10877,"journal":{"name":"Current Research in Pharmacology and Drug Discovery","volume":"6 ","pages":"Article 100177"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S259025712400004X/pdfft?md5=7649143687736ada6e8a2ab879020a7e&pid=1-s2.0-S259025712400004X-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139653033","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
GERD: Latest update on acid-suppressant drugs 胃食管反流病抑酸药物的最新进展
Q2 Agricultural and Biological Sciences Pub Date : 2024-01-01 DOI: 10.1016/j.crphar.2024.100198
Zyad AL-Frejat , Nafiza Martini , Alia Esper , Diana Al-Frejat , Samer Younes , Majd Hanna

GERD is a very familiar diagnosis among health care providers due to its massive spread, and its symptoms can affect the quality of life for a respectable slice of its patients. Therefore, what can only be described as a logical consequence, a pursuit of a treatment that can both relieve symptoms and have minimal side effects is still ongoing to cover the large demographic affected by GERD. In the following review, analysis will be made of GERD, including possible regulatory activity, of certain drugs to the already discussed pathways involved in GERD patients.

胃食管反流病由于其广泛的传播性,在医疗服务提供者中是一个非常熟悉的诊断,其症状会影响相当一部分患者的生活质量。因此,为了覆盖受胃食管反流病影响的广大人群,人们仍在不断寻求一种既能缓解症状又能将副作用降到最低的治疗方法,这可以说是顺理成章的事情。在下面的综述中,我们将对胃食管反流病进行分析,包括某些药物可能对胃食管反流病患者的相关途径产生的调节作用。
{"title":"GERD: Latest update on acid-suppressant drugs","authors":"Zyad AL-Frejat ,&nbsp;Nafiza Martini ,&nbsp;Alia Esper ,&nbsp;Diana Al-Frejat ,&nbsp;Samer Younes ,&nbsp;Majd Hanna","doi":"10.1016/j.crphar.2024.100198","DOIUrl":"10.1016/j.crphar.2024.100198","url":null,"abstract":"<div><p>GERD is a very familiar diagnosis among health care providers due to its massive spread, and its symptoms can affect the quality of life for a respectable slice of its patients. Therefore, what can only be described as a logical consequence, a pursuit of a treatment that can both relieve symptoms and have minimal side effects is still ongoing to cover the large demographic affected by GERD. In the following review, analysis will be made of GERD, including possible regulatory activity, of certain drugs to the already discussed pathways involved in GERD patients.</p></div>","PeriodicalId":10877,"journal":{"name":"Current Research in Pharmacology and Drug Discovery","volume":"7 ","pages":"Article 100198"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590257124000257/pdfft?md5=e6c868901ce49b17b1265e7cd2f8052c&pid=1-s2.0-S2590257124000257-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142076694","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Ferroptosis induces nucleolar stress as revealed by live-cell imaging using thioflavin T 使用硫黄素 T 进行活细胞成像显示铁突变诱导细胞核应激
Q2 Agricultural and Biological Sciences Pub Date : 2024-01-01 DOI: 10.1016/j.crphar.2024.100196
Yoko Hirata , Hiroshi Takemori , Kyoji Furuta , Yuji O. Kamatari , Makoto Sawada

Nucleolar stress induced by stressors like hypoxia, UV irradiation, and heat shock downregulates ribosomal RNA transcription, thereby impairing protein synthesis capacity and potentially contributing to cell senescence and various human diseases such as neurodegenerative disorders and cancer. Live-cell imaging of the nucleolus may be a feasible strategy for investigating nucleolar stress, but currently available nucleolar stains are limited for this application. In this study using mouse hippocampal HT22 cells, we demonstrate that thioflavin T (ThT), a benzothiazole dye that binds RNA with high affinity, is useful for nucleolar imaging in cells where RNAs predominate over protein aggregates. Nucleoli were stained with high intensity simply by adding ThT to the cell culture medium, making it suitable for use even in damaged cells. Further, ThT staining overlapped with specific nucleolar stains in both live and fixed cells, but did not overlap with markers for mitochondria, lysosomes, endoplasmic reticulum, and double-stranded DNA. Ferroptosis, an iron-dependent nonapoptotic cell death pathway characterized by lipid peroxide accumulation, reduced the number of ThT-positive puncta while endoplasmic reticulum stress did not. These findings suggest that ferroptosis is associated with oxidative damage to nucleolar RNA molecules and ensuing loss of nucleolar function.

缺氧、紫外线照射和热休克等应激源诱导的核极应激会降低核糖体 RNA 的转录,从而损害蛋白质合成能力,并可能导致细胞衰老和各种人类疾病,如神经退行性疾病和癌症。核小体的活细胞成像可能是研究核小体应激的一种可行策略,但目前可用的核小体染色剂在这方面的应用有限。在这项使用小鼠海马 HT22 细胞进行的研究中,我们证明了硫黄素 T(ThT)--一种能与 RNA 高亲和力结合的苯并噻唑染料--在 RNA 多于蛋白质聚集的细胞中可用于核小体成像。只需在细胞培养基中加入 ThT,核小体就能得到高强度染色,因此即使在受损细胞中也能使用。此外,在活细胞和固定细胞中,ThT 染色与特定的核染色重叠,但与线粒体、溶酶体、内质网和双链 DNA 标记不重叠。铁凋亡是一种以过氧化脂质积累为特征的铁依赖性非凋亡细胞死亡途径,它能减少 ThT 阳性点的数量,而内质网应激则不会。这些发现表明,铁卟啉中毒与核小体 RNA 分子的氧化损伤以及随之而来的核小体功能丧失有关。
{"title":"Ferroptosis induces nucleolar stress as revealed by live-cell imaging using thioflavin T","authors":"Yoko Hirata ,&nbsp;Hiroshi Takemori ,&nbsp;Kyoji Furuta ,&nbsp;Yuji O. Kamatari ,&nbsp;Makoto Sawada","doi":"10.1016/j.crphar.2024.100196","DOIUrl":"https://doi.org/10.1016/j.crphar.2024.100196","url":null,"abstract":"<div><p>Nucleolar stress induced by stressors like hypoxia, UV irradiation, and heat shock downregulates ribosomal RNA transcription, thereby impairing protein synthesis capacity and potentially contributing to cell senescence and various human diseases such as neurodegenerative disorders and cancer. Live-cell imaging of the nucleolus may be a feasible strategy for investigating nucleolar stress, but currently available nucleolar stains are limited for this application. In this study using mouse hippocampal HT22 cells, we demonstrate that thioflavin T (ThT), a benzothiazole dye that binds RNA with high affinity, is useful for nucleolar imaging in cells where RNAs predominate over protein aggregates. Nucleoli were stained with high intensity simply by adding ThT to the cell culture medium, making it suitable for use even in damaged cells. Further, ThT staining overlapped with specific nucleolar stains in both live and fixed cells, but did not overlap with markers for mitochondria, lysosomes, endoplasmic reticulum, and double-stranded DNA. Ferroptosis, an iron-dependent nonapoptotic cell death pathway characterized by lipid peroxide accumulation, reduced the number of ThT-positive puncta while endoplasmic reticulum stress did not. These findings suggest that ferroptosis is associated with oxidative damage to nucleolar RNA molecules and ensuing loss of nucleolar function.</p></div>","PeriodicalId":10877,"journal":{"name":"Current Research in Pharmacology and Drug Discovery","volume":"7 ","pages":"Article 100196"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590257124000233/pdfft?md5=c1089fbc0a10fc2cfe01e0f9b383037a&pid=1-s2.0-S2590257124000233-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141582193","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The relationship between gender and pharmacology 性别与药理学的关系
Q2 Agricultural and Biological Sciences Pub Date : 2024-01-01 DOI: 10.1016/j.crphar.2024.100192
Samer Younes

The part of sexuality in pharmacology research was not acknowledged, and it was not thought-out to be a determinant that could impact strength and disease. For decades research has mainly contained male, women and animals, leading to a lack of news about syndromes in females. Still, it is critical to guarantee equal likeness so that determine the security, influence, and resistance of healing agents for all individuals. The underrepresentation of female models in preclinical studies over various decades has surpassed to disparities in the understanding, disease, and treatment of ailments 'tween genders. The closeness of sexuality bias has happened recognized as a contributing determinant to the restricted interpretation and replicability of preclinical research. Many demands operation have stressed the significance of including sexuality as a organic changeable, and this view is acquire growing support. Regardless of important progress in incorporating more female models into preclinical studies, differences prevail contemporary. The current review focuses on the part of sexuality and common in biomedical research and, therefore, their potential function in pharmacology and analyze the potential risks guide.

性在药理学研究中的作用没有得到承认,也没有被认为是影响体力和疾病的决定因素。几十年来,研究对象主要是男性、女性和动物,因此缺乏关于女性综合征的新闻。尽管如此,保证平等的相似性至关重要,这样才能确定所有个体的安全性、影响力和对治疗剂的抵抗力。几十年来,临床前研究中女性模型的代表性不足,导致了两性在疾病的理解、疾病和治疗方面的差异。人们已经认识到,性别偏见是导致临床前研究的解释和可复制性受到限制的一个决定性因素。许多需求操作都强调了将性行为作为有机可变因素的重要性,这一观点正获得越来越多的支持。尽管在将更多女性模型纳入临床前研究方面取得了重要进展,但目前仍存在差异。目前的综述重点关注生物医学研究中性与共性的部分,因此,它们在药理学中的潜在功能,并分析潜在的风险指南。
{"title":"The relationship between gender and pharmacology","authors":"Samer Younes","doi":"10.1016/j.crphar.2024.100192","DOIUrl":"https://doi.org/10.1016/j.crphar.2024.100192","url":null,"abstract":"<div><p>The part of sexuality in pharmacology research was not acknowledged, and it was not thought-out to be a determinant that could impact strength and disease. For decades research has mainly contained male, women and animals, leading to a lack of news about syndromes in females. Still, it is critical to guarantee equal likeness so that determine the security, influence, and resistance of healing agents for all individuals. The underrepresentation of female models in preclinical studies over various decades has surpassed to disparities in the understanding, disease, and treatment of ailments 'tween genders. The closeness of sexuality bias has happened recognized as a contributing determinant to the restricted interpretation and replicability of preclinical research. Many demands operation have stressed the significance of including sexuality as a organic changeable, and this view is acquire growing support. Regardless of important progress in incorporating more female models into preclinical studies, differences prevail contemporary. The current review focuses on the part of sexuality and common in biomedical research and, therefore, their potential function in pharmacology and analyze the potential risks guide.</p></div>","PeriodicalId":10877,"journal":{"name":"Current Research in Pharmacology and Drug Discovery","volume":"7 ","pages":"Article 100192"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590257124000191/pdfft?md5=84ec4ebf59cf69e4cb759969e8c29920&pid=1-s2.0-S2590257124000191-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"141595995","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Coumarin: A natural solution for alleviating inflammatory disorders 香豆素:缓解炎症的天然方法
Q2 Agricultural and Biological Sciences Pub Date : 2024-01-01 DOI: 10.1016/j.crphar.2024.100202
Farnoosh Saadati , Amir Modarresi Chahardehi , Negar Jamshidi , Nazanin Jamshidi , Darioush Ghasemi
Coumarin, a naturally occurring compound found in various plants, has a rich history of use in traditional medicine. Recent research has highlighted its anti-inflammatory properties, positioning it as a promising candidate for treating inflammatory disorders such as rheumatoid arthritis, asthma, and inflammatory bowel disease. This narrative review aims to comprehensively summarize the current knowledge regarding coumarin's pharmacological effects in alleviating inflammatory conditions by analyzing preclinical and clinical studies. The review focuses on elucidating the mechanisms through which coumarin exerts its anti-inflammatory effects, including its antioxidant activity, inhibiting pro-inflammatory cytokine production, and modulation of immune cell functions. Additionally, the paper addresses potential limitations of using coumarin, such as concerns about toxicity at high doses or with prolonged use. Before widespread clinical application, further investigation is needed to fully understand coumarin's potential benefits and risks.
香豆素是一种存在于多种植物中的天然化合物,在传统医学中的应用历史悠久。最近的研究突出了香豆素的抗炎特性,将其定位为治疗类风湿性关节炎、哮喘和炎症性肠病等炎症性疾病的有前途的候选药物。这篇叙述性综述旨在通过分析临床前和临床研究,全面总结目前有关香豆素缓解炎症的药理作用的知识。综述重点阐明了香豆素发挥抗炎作用的机制,包括其抗氧化活性、抑制促炎细胞因子的产生以及调节免疫细胞的功能。此外,论文还探讨了使用香豆素的潜在局限性,如担心高剂量或长期使用会产生毒性。在广泛应用于临床之前,需要进行进一步的调查,以充分了解香豆素的潜在益处和风险。
{"title":"Coumarin: A natural solution for alleviating inflammatory disorders","authors":"Farnoosh Saadati ,&nbsp;Amir Modarresi Chahardehi ,&nbsp;Negar Jamshidi ,&nbsp;Nazanin Jamshidi ,&nbsp;Darioush Ghasemi","doi":"10.1016/j.crphar.2024.100202","DOIUrl":"10.1016/j.crphar.2024.100202","url":null,"abstract":"<div><div>Coumarin, a naturally occurring compound found in various plants, has a rich history of use in traditional medicine. Recent research has highlighted its anti-inflammatory properties, positioning it as a promising candidate for treating inflammatory disorders such as rheumatoid arthritis, asthma, and inflammatory bowel disease. This narrative review aims to comprehensively summarize the current knowledge regarding coumarin's pharmacological effects in alleviating inflammatory conditions by analyzing preclinical and clinical studies. The review focuses on elucidating the mechanisms through which coumarin exerts its anti-inflammatory effects, including its antioxidant activity, inhibiting pro-inflammatory cytokine production, and modulation of immune cell functions. Additionally, the paper addresses potential limitations of using coumarin, such as concerns about toxicity at high doses or with prolonged use. Before widespread clinical application, further investigation is needed to fully understand coumarin's potential benefits and risks.</div></div>","PeriodicalId":10877,"journal":{"name":"Current Research in Pharmacology and Drug Discovery","volume":"7 ","pages":"Article 100202"},"PeriodicalIF":0.0,"publicationDate":"2024-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"142322699","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Flavonoids as promising molecules in the cancer therapy: An insight 黄酮类化合物是治疗癌症的理想分子:深入了解
Q2 Agricultural and Biological Sciences Pub Date : 2023-12-08 DOI: 10.1016/j.crphar.2023.100167
Suhail Ahmad Mir , Ashraf Dar , Laraibah Hamid , Nasir Nisar , Jonaid Ahmad Malik , Tabasum Ali , Ghulam Nabi Bader

Cancer continues to increase global morbidity and mortality rates. Despite substantial progress in the development of various chemically synthesized anti-cancer drugs, the poor prognosis of the disease still remains a big challenge. The most common drawback of conventional cancer therapies is the emergence of drug resistance eventually leading to the discontinuation of chemotherapy. Moreover, advanced target-specific therapies including immunotherapy and stem cell therapy are expensive enough and are unaffordable for most patients in poorer nations. Therefore, alternative and cheaper therapeutic strategies are needed to complement the current cancer treatment approaches. Phytochemicals are bioactive compounds produced naturally by plants and have great potential in human health and disease. These compounds possess antiproliferative, anti-oxidant, and immunomodulatory properties. Among the phytochemicals, flavonoids are very effective in treating a wide range of diseases from cardiovascular diseases and immunological disorders to cancer. They scavenge reactive oxygen species (ROS), inhibit cancer metastasis, modulate the immune system and induce apoptotic or autophagic cell death in cancers. This review will discuss the potential of various phytochemicals particularly flavonoids in attempts to target various cancers.

癌症继续增加全球的发病率和死亡率。尽管在开发各种化学合成抗癌药物方面取得了重大进展,但癌症的不良预后仍然是一个巨大挑战。传统癌症疗法最常见的缺点是出现耐药性,最终导致化疗中断。此外,包括免疫疗法和干细胞疗法在内的先进靶向疗法费用昂贵,贫穷国家的大多数患者都负担不起。因此,需要有更便宜的替代治疗策略来补充目前的癌症治疗方法。植物化学物质是植物天然产生的生物活性化合物,在人类健康和疾病方面具有巨大潜力。这些化合物具有抗增殖、抗氧化和免疫调节的特性。在植物化学物质中,类黄酮对治疗从心血管疾病、免疫紊乱到癌症等多种疾病非常有效。它们能清除活性氧(ROS),抑制癌症转移,调节免疫系统,诱导癌症细胞凋亡或自噬。本综述将讨论各种植物化学物质(尤其是类黄酮)在针对各种癌症方面的潜力。
{"title":"Flavonoids as promising molecules in the cancer therapy: An insight","authors":"Suhail Ahmad Mir ,&nbsp;Ashraf Dar ,&nbsp;Laraibah Hamid ,&nbsp;Nasir Nisar ,&nbsp;Jonaid Ahmad Malik ,&nbsp;Tabasum Ali ,&nbsp;Ghulam Nabi Bader","doi":"10.1016/j.crphar.2023.100167","DOIUrl":"https://doi.org/10.1016/j.crphar.2023.100167","url":null,"abstract":"<div><p>Cancer continues to increase global morbidity and mortality rates. Despite substantial progress in the development of various chemically synthesized anti-cancer drugs, the poor prognosis of the disease still remains a big challenge. The most common drawback of conventional cancer therapies is the emergence of drug resistance eventually leading to the discontinuation of chemotherapy. Moreover, advanced target-specific therapies including immunotherapy and stem cell therapy are expensive enough and are unaffordable for most patients in poorer nations. Therefore, alternative and cheaper therapeutic strategies are needed to complement the current cancer treatment approaches. Phytochemicals are bioactive compounds produced naturally by plants and have great potential in human health and disease. These compounds possess antiproliferative, anti-oxidant, and immunomodulatory properties. Among the phytochemicals, flavonoids are very effective in treating a wide range of diseases from cardiovascular diseases and immunological disorders to cancer. They scavenge reactive oxygen species (ROS), inhibit cancer metastasis, modulate the immune system and induce apoptotic or autophagic cell death in cancers. This review will discuss the potential of various phytochemicals particularly flavonoids in attempts to target various cancers.</p></div>","PeriodicalId":10877,"journal":{"name":"Current Research in Pharmacology and Drug Discovery","volume":"6 ","pages":"Article 100167"},"PeriodicalIF":0.0,"publicationDate":"2023-12-08","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://www.sciencedirect.com/science/article/pii/S2590257123000159/pdfft?md5=63bdd0b512d443d3b85d52b88824e745&pid=1-s2.0-S2590257123000159-main.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"138577643","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Guiding stem cells for cutaneous repair 引导干细胞进行皮肤修复
Q2 Agricultural and Biological Sciences Pub Date : 2023-01-01 DOI: 10.1016/j.crphar.2022.100145
Shivani Desai , Juilee Jagtap , Shivani Sainani , Ramesh Bhonde

The significance of mesenchymal stem cells (MSCs) for tissue repair and regeneration is widely recognized. The pleiotropic nature of MSCs is demonstrated by their potential for proliferation and differentiation, and paracrine secretions, thereby making them ideal candidates for cell replacement therapy. Tissue resident MSCs are engaged in homeostasis under normal wear and tear. However, stem cell therapy may be applicable if damage cannot be repaired by normal homeostatic mechanisms. The safety of MSCs has been clearly established in clinical trials but their efficacy remains questionable. The efficacy of MSCs depends on several factors, such as their viability, functional status in terms of secretome secretions, and the in-vivo scenario after transplantation. The performance of MSCs is regulated by their micro-environmental conditions and cues. The so-called MSC niche comprises physical, chemical, and biological components, which play key roles in determining the fate of MSCs. MSCs scaled up for transplantation purposes comprise a disorganized mass of cells, which needs to be directed to perform the required function. Thus, MSCs need to be directed toward an expected target activity in human patients. This review focuses on the various methods that can be used to guide stem cells for cutaneous repair.

间充质干细胞(MSCs)在组织修复和再生中的意义已得到广泛认可。骨髓间充质干细胞的多效性通过其增殖和分化的潜力以及旁分泌分泌物得到证明,从而使其成为细胞替代治疗的理想候选者。驻留在组织中的MSCs在正常磨损下参与体内平衡。然而,如果损伤不能通过正常的稳态机制修复,干细胞治疗可能是适用的。骨髓间充质干细胞的安全性已在临床试验中得到明确证实,但其疗效仍存疑。MSCs的疗效取决于几个因素,如其生存能力、分泌组分泌物的功能状态以及移植后的体内情况。MSC的性能受其微观环境条件和线索的调节。所谓的MSC生态位包括物理、化学和生物成分,这些成分在决定MSC的命运中起着关键作用。为移植目的放大的MSCs包括无序的细胞团,需要引导其执行所需的功能。因此,MSCs需要针对人类患者的预期靶活性。本文综述了可用于引导干细胞进行皮肤修复的各种方法。
{"title":"Guiding stem cells for cutaneous repair","authors":"Shivani Desai ,&nbsp;Juilee Jagtap ,&nbsp;Shivani Sainani ,&nbsp;Ramesh Bhonde","doi":"10.1016/j.crphar.2022.100145","DOIUrl":"10.1016/j.crphar.2022.100145","url":null,"abstract":"<div><p>The significance of mesenchymal stem cells (MSCs) for tissue repair and regeneration is widely recognized. The pleiotropic nature of MSCs is demonstrated by their potential for proliferation and differentiation, and paracrine secretions, thereby making them ideal candidates for cell replacement therapy. Tissue resident MSCs are engaged in homeostasis under normal wear and tear. However, stem cell therapy may be applicable if damage cannot be repaired by normal homeostatic mechanisms. The safety of MSCs has been clearly established in clinical trials but their efficacy remains questionable. The efficacy of MSCs depends on several factors, such as their viability, functional status in terms of secretome secretions, and the in-vivo scenario after transplantation. The performance of MSCs is regulated by their micro-environmental conditions and cues. The so-called MSC niche comprises physical, chemical, and biological components, which play key roles in determining the fate of MSCs. MSCs scaled up for transplantation purposes comprise a disorganized mass of cells, which needs to be directed to perform the required function. Thus, MSCs need to be directed toward an expected target activity in human patients. This review focuses on the various methods that can be used to guide stem cells for cutaneous repair.</p></div>","PeriodicalId":10877,"journal":{"name":"Current Research in Pharmacology and Drug Discovery","volume":"4 ","pages":"Article 100145"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/3c/c4/main.PMC9761596.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"10424542","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Present status with impacts and roles of miRNA on Soil Transmitted Helminthiosis control: A review miRNA在土壤传播性蠕虫病防治中的作用及影响研究进展
Q2 Agricultural and Biological Sciences Pub Date : 2023-01-01 DOI: 10.1016/j.crphar.2023.100162
Imon Mitra , Arijit Bhattacharya , Joydeep Paul , Anisuzzaman

Soil-Transmitted Helminthiasis (STH) is one of the most widespread Neglected Tropical Diseases (NTDs), and almost 1.5 billion of the global population is affected, mostly in the indigent, countryside sectors of tropics/subtropics. STH, commonly caused by various nematodes, adversely affects the hosts’ growth, cognatic development, and immunity. Albendazole is most commonly used against STH (Soil-Transmitted Helminths) but resistance has already been reported in different countries. To date, no effective vaccine is present against STH. miRNAs are a unique class of small non-coding RNA, regulating various biological activities indulging host immune responses in host-pathogen interaction of STH. Dysregulation of miRNAs are being considered as one of the most important aspect of host-parasite interactions. Thus, it is the prime importance to identify and characterize parasite-specific as well as host-derived miRNAs to understand the STH infection at the molecular level. Systematic bibliometric analysis reveals a huge knowledge gap in understanding the disease by using both host and parasitic miRNAs as a potential biomarker. In this study, we addressed the present status of the STH prevalence, and therapy under the light of miRNAs. This would further help in designing new inhibitors and therapeutic strategies to control STH.

土壤传播蠕虫病(STH)是最广泛的被忽视热带疾病之一,全球近15亿人口受到影响,主要发生在热带/亚热带的贫困农村地区。STH通常由各种线虫引起,对宿主的生长、同源发育和免疫力产生不利影响。阿苯达唑最常用于对抗STH(土壤传播蠕虫),但不同国家已经报道了耐药性。到目前为止,还没有针对STH的有效疫苗。miRNA是一类独特的小型非编码RNA,在STH的宿主-病原体相互作用中调节宿主免疫反应的各种生物活性。miRNA的失调被认为是宿主-寄生虫相互作用的最重要方面之一。因此,识别和表征寄生虫特异性以及宿主衍生的miRNA对于在分子水平上了解STH感染至关重要。系统的文献计量分析揭示了通过使用宿主和寄生miRNA作为潜在的生物标志物来理解这种疾病的巨大知识差距。在这项研究中,我们讨论了STH患病率的现状,以及miRNA的治疗。这将进一步有助于设计新的抑制剂和治疗策略来控制STH。
{"title":"Present status with impacts and roles of miRNA on Soil Transmitted Helminthiosis control: A review","authors":"Imon Mitra ,&nbsp;Arijit Bhattacharya ,&nbsp;Joydeep Paul ,&nbsp;Anisuzzaman","doi":"10.1016/j.crphar.2023.100162","DOIUrl":"10.1016/j.crphar.2023.100162","url":null,"abstract":"<div><p>Soil-Transmitted Helminthiasis (STH) is one of the most widespread Neglected Tropical Diseases (NTDs), and almost 1.5 billion of the global population is affected, mostly in the indigent, countryside sectors of tropics/subtropics. STH, commonly caused by various nematodes, adversely affects the hosts’ growth, cognatic development, and immunity. Albendazole is most commonly used against STH (Soil-Transmitted Helminths) but resistance has already been reported in different countries. To date, no effective vaccine is present against STH. miRNAs are a unique class of small non-coding RNA, regulating various biological activities indulging host immune responses in host-pathogen interaction of STH. Dysregulation of miRNAs are being considered as one of the most important aspect of host-parasite interactions. Thus, it is the prime importance to identify and characterize parasite-specific as well as host-derived miRNAs to understand the STH infection at the molecular level. Systematic bibliometric analysis reveals a huge knowledge gap in understanding the disease by using both host and parasitic miRNAs as a potential biomarker. In this study, we addressed the present status of the STH prevalence, and therapy under the light of miRNAs. This would further help in designing new inhibitors and therapeutic strategies to control STH.</p></div>","PeriodicalId":10877,"journal":{"name":"Current Research in Pharmacology and Drug Discovery","volume":"5 ","pages":"Article 100162"},"PeriodicalIF":0.0,"publicationDate":"2023-01-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://ftp.ncbi.nlm.nih.gov/pub/pmc/oa_pdf/c9/5b/main.PMC10371793.pdf","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"9963935","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"OA","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Current Research in Pharmacology and Drug Discovery
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1